These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24801586)

  • 41. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adrenal medulla secretion in Cushing's syndrome.
    Mannelli M; Lanzillotti R; Pupilli C; Ianni L; Conti A; Serio M
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1331-5. PubMed ID: 8200934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome.
    Boscaro M; Sonino N; Scarda A; Barzon L; Fallo F; Sartori MT; Patrassi GM; Girolami A
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3662-6. PubMed ID: 12161492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients with Cushing's syndrome are care-intensive even in the era of laparoscopic adrenalectomy.
    Kissane NA; Cendan JC
    Am Surg; 2009 Apr; 75(4):279-83. PubMed ID: 19385284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
    Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission.
    Aranda G; Fernandez-Ruiz R; Palomo M; Romo M; Mora M; Halperin I; Casals G; Enseñat J; Vidal O; Diaz-Ricart M; Hanzu FA
    Clin Endocrinol (Oxf); 2018 Mar; 88(3):415-424. PubMed ID: 29154455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature.
    da Mota F; Murray C; Ezzat S
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1670-4. PubMed ID: 21816785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypercoagulable state in Cushing's syndrome is reversible following remission.
    Kastelan D; Dusek T; Kraljevic I; Aganovic I
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):102-6. PubMed ID: 22724622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach.
    Varlamov EV; Langlois F; Vila G; Fleseriu M
    Eur J Endocrinol; 2021 Apr; 184(5):R207-R224. PubMed ID: 33539319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess.
    Pivonello R; De Martino MC; Iacuaniello D; Simeoli C; Muscogiuri G; Carlomagno F; De Leo M; Cozzolino A; Colao A
    Front Horm Res; 2016; 46():54-65. PubMed ID: 27212264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome.
    Crespo I; Esther GM; Santos A; Valassi E; Yolanda VG; De Juan-Delago M; Webb SM; Gómez-Ansón B; Resmini E
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):826-33. PubMed ID: 25052342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality and morbidity in Cushing's syndrome in New Zealand.
    Bolland MJ; Holdaway IM; Berkeley JE; Lim S; Dransfield WJ; Conaglen JV; Croxson MS; Gamble GD; Hunt PJ; Toomath RJ
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):436-42. PubMed ID: 21609352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.
    Yiu KH; Marsan NA; Delgado V; Biermasz NR; Holman ER; Smit JW; Feelders RA; Bax JJ; Pereira AM
    Eur J Endocrinol; 2012 Jan; 166(1):27-34. PubMed ID: 22004909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment.
    Akaza I; Yoshimoto T; Iwashima F; Nakayama C; Doi M; Izumiyama H; Hirata Y
    Hypertens Res; 2011 Oct; 34(10):1111-5. PubMed ID: 21775997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
    Valassi E; Crespo I; Gich I; Rodríguez J; Webb SM
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):735-42. PubMed ID: 22533782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Cushing's syndrome - Endogenous hypercortisolemia on cardiovascular autonomic functions.
    Jyotsna VP; Naseer A; Sreenivas V; Gupta N; Deepak KK
    Auton Neurosci; 2011 Feb; 160(1-2):99-102. PubMed ID: 21177144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac disease in Cushing's syndrome. Emphasis on the role of cardiovascular magnetic resonance imaging.
    Moustaki M; Markousis-Mavrogenis G; Vryonidou A; Paschou SA; Mavrogeni S
    Endocrine; 2024 Mar; 83(3):548-558. PubMed ID: 38129722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.